Article in Neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
5 citing papers in PubMed, 23 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
13 authors at 1 institution in 5 countries.
Omar K SiddiqiFrom the Department of Internal Medicine (O.K.S., L.H.), University of Zambia School of Medicine, Lusaka; Global Neurology Program (O.K.S.), Division of Neuroimmunology, Center for Virology and Vaccine Research, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; Ministry of Health (M.K., E.C.-K.); ASPPH/CDC Allan Rosenfield Global Health Fellowship Program (R.K.), Lusaka; Department of Public Health and Research (A.N.M.) and Zambia Field Epidemiology Training Program (P.K.), Ministry of Health; World Health Organization (M.L.M.); Virology Laboratory (M.L.M.) and Department of Physiotherapy (M.N.M.), Children's Hospital, University Teaching Hospital, Lusaka, Zambia; Institute of Human Virology (L.H.), Division of Infectious Diseases, Department of Medicine, University of Maryland School of Medicine, Baltimore; Zambia Agriculture Research Institute (P.C.C.), Plant Protection and Quarantine Division, Lusaka; and Centers for Disease Control and Prevention (M.M.-E., J.M.J., H.C.B.), Atlanta, GA. osiddiqi@bidmc.harvard.edu.
Muzala KapinaFrom the Department of Internal Medicine (O.K.S., L.H.), University of Zambia School of Medicine, Lusaka; Global Neurology Program (O.K.S.), Division of Neuroimmunology, Center for Virology and Vaccine Research, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; Ministry of Health (M.K., E.C.-K.); ASPPH/CDC Allan Rosenfield Global Health Fellowship Program (R.K.), Lusaka; Department of Public Health and Research (A.N.M.) and Zambia Field Epidemiology Training Program (P.K.), Ministry of Health; World Health Organization (M.L.M.); Virology Laboratory (M.L.M.) and Department of Physiotherapy (M.N.M.), Children's Hospital, University Teaching Hospital, Lusaka, Zambia; Institute of Human Virology (L.H.), Division of Infectious Diseases, Department of Medicine, University of Maryland School of Medicine, Baltimore; Zambia Agriculture Research Institute (P.C.C.), Plant Protection and Quarantine Division, Lusaka; and Centers for Disease Control and Prevention (M.M.-E., J.M.J., H.C.B.), Atlanta, GA.ORCID 0000-0002-8469-9108
Ramya KumarFrom the Department of Internal Medicine (O.K.S., L.H.), University of Zambia School of Medicine, Lusaka; Global Neurology Program (O.K.S.), Division of Neuroimmunology, Center for Virology and Vaccine Research, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; Ministry of Health (M.K., E.C.-K.); ASPPH/CDC Allan Rosenfield Global Health Fellowship Program (R.K.), Lusaka; Department of Public Health and Research (A.N.M.) and Zambia Field Epidemiology Training Program (P.K.), Ministry of Health; World Health Organization (M.L.M.); Virology Laboratory (M.L.M.) and Department of Physiotherapy (M.N.M.), Children's Hospital, University Teaching Hospital, Lusaka, Zambia; Institute of Human Virology (L.H.), Division of Infectious Diseases, Department of Medicine, University of Maryland School of Medicine, Baltimore; Zambia Agriculture Research Institute (P.C.C.), Plant Protection and Quarantine Division, Lusaka; and Centers for Disease Control and Prevention (M.M.-E., J.M.J., H.C.B.), Atlanta, GA.ORCID 0000-0002-4570-6686
Albertina Ngomah MoraesFrom the Department of Internal Medicine (O.K.S., L.H.), University of Zambia School of Medicine, Lusaka; Global Neurology Program (O.K.S.), Division of Neuroimmunology, Center for Virology and Vaccine Research, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; Ministry of Health (M.K., E.C.-K.); ASPPH/CDC Allan Rosenfield Global Health Fellowship Program (R.K.), Lusaka; Department of Public Health and Research (A.N.M.) and Zambia Field Epidemiology Training Program (P.K.), Ministry of Health; World Health Organization (M.L.M.); Virology Laboratory (M.L.M.) and Department of Physiotherapy (M.N.M.), Children's Hospital, University Teaching Hospital, Lusaka, Zambia; Institute of Human Virology (L.H.), Division of Infectious Diseases, Department of Medicine, University of Maryland School of Medicine, Baltimore; Zambia Agriculture Research Institute (P.C.C.), Plant Protection and Quarantine Division, Lusaka; and Centers for Disease Control and Prevention (M.M.-E., J.M.J., H.C.B.), Atlanta, GA.ORCID 0000-0002-3435-1170
Patrick KabweFrom the Department of Internal Medicine (O.K.S., L.H.), University of Zambia School of Medicine, Lusaka; Global Neurology Program (O.K.S.), Division of Neuroimmunology, Center for Virology and Vaccine Research, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; Ministry of Health (M.K., E.C.-K.); ASPPH/CDC Allan Rosenfield Global Health Fellowship Program (R.K.), Lusaka; Department of Public Health and Research (A.N.M.) and Zambia Field Epidemiology Training Program (P.K.), Ministry of Health; World Health Organization (M.L.M.); Virology Laboratory (M.L.M.) and Department of Physiotherapy (M.N.M.), Children's Hospital, University Teaching Hospital, Lusaka, Zambia; Institute of Human Virology (L.H.), Division of Infectious Diseases, Department of Medicine, University of Maryland School of Medicine, Baltimore; Zambia Agriculture Research Institute (P.C.C.), Plant Protection and Quarantine Division, Lusaka; and Centers for Disease Control and Prevention (M.M.-E., J.M.J., H.C.B.), Atlanta, GA.ORCID 0000-0003-4364-0019
Mazyanga L MazabaFrom the Department of Internal Medicine (O.K.S., L.H.), University of Zambia School of Medicine, Lusaka; Global Neurology Program (O.K.S.), Division of Neuroimmunology, Center for Virology and Vaccine Research, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; Ministry of Health (M.K., E.C.-K.); ASPPH/CDC Allan Rosenfield Global Health Fellowship Program (R.K.), Lusaka; Department of Public Health and Research (A.N.M.) and Zambia Field Epidemiology Training Program (P.K.), Ministry of Health; World Health Organization (M.L.M.); Virology Laboratory (M.L.M.) and Department of Physiotherapy (M.N.M.), Children's Hospital, University Teaching Hospital, Lusaka, Zambia; Institute of Human Virology (L.H.), Division of Infectious Diseases, Department of Medicine, University of Maryland School of Medicine, Baltimore; Zambia Agriculture Research Institute (P.C.C.), Plant Protection and Quarantine Division, Lusaka; and Centers for Disease Control and Prevention (M.M.-E., J.M.J., H.C.B.), Atlanta, GA.ORCID 0000-0002-5465-5710
Lottie HachaambwaFrom the Department of Internal Medicine (O.K.S., L.H.), University of Zambia School of Medicine, Lusaka; Global Neurology Program (O.K.S.), Division of Neuroimmunology, Center for Virology and Vaccine Research, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; Ministry of Health (M.K., E.C.-K.); ASPPH/CDC Allan Rosenfield Global Health Fellowship Program (R.K.), Lusaka; Department of Public Health and Research (A.N.M.) and Zambia Field Epidemiology Training Program (P.K.), Ministry of Health; World Health Organization (M.L.M.); Virology Laboratory (M.L.M.) and Department of Physiotherapy (M.N.M.), Children's Hospital, University Teaching Hospital, Lusaka, Zambia; Institute of Human Virology (L.H.), Division of Infectious Diseases, Department of Medicine, University of Maryland School of Medicine, Baltimore; Zambia Agriculture Research Institute (P.C.C.), Plant Protection and Quarantine Division, Lusaka; and Centers for Disease Control and Prevention (M.M.-E., J.M.J., H.C.B.), Atlanta, GA.ORCID 0000-0003-0454-9511
Namalambo Mwenda Ng'uniFrom the Department of Internal Medicine (O.K.S., L.H.), University of Zambia School of Medicine, Lusaka; Global Neurology Program (O.K.S.), Division of Neuroimmunology, Center for Virology and Vaccine Research, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; Ministry of Health (M.K., E.C.-K.); ASPPH/CDC Allan Rosenfield Global Health Fellowship Program (R.K.), Lusaka; Department of Public Health and Research (A.N.M.) and Zambia Field Epidemiology Training Program (P.K.), Ministry of Health; World Health Organization (M.L.M.); Virology Laboratory (M.L.M.) and Department of Physiotherapy (M.N.M.), Children's Hospital, University Teaching Hospital, Lusaka, Zambia; Institute of Human Virology (L.H.), Division of Infectious Diseases, Department of Medicine, University of Maryland School of Medicine, Baltimore; Zambia Agriculture Research Institute (P.C.C.), Plant Protection and Quarantine Division, Lusaka; and Centers for Disease Control and Prevention (M.M.-E., J.M.J., H.C.B.), Atlanta, GA.ORCID 0000-0002-4164-1811
Patrick C ChikotiFrom the Department of Internal Medicine (O.K.S., L.H.), University of Zambia School of Medicine, Lusaka; Global Neurology Program (O.K.S.), Division of Neuroimmunology, Center for Virology and Vaccine Research, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; Ministry of Health (M.K., E.C.-K.); ASPPH/CDC Allan Rosenfield Global Health Fellowship Program (R.K.), Lusaka; Department of Public Health and Research (A.N.M.) and Zambia Field Epidemiology Training Program (P.K.), Ministry of Health; World Health Organization (M.L.M.); Virology Laboratory (M.L.M.) and Department of Physiotherapy (M.N.M.), Children's Hospital, University Teaching Hospital, Lusaka, Zambia; Institute of Human Virology (L.H.), Division of Infectious Diseases, Department of Medicine, University of Maryland School of Medicine, Baltimore; Zambia Agriculture Research Institute (P.C.C.), Plant Protection and Quarantine Division, Lusaka; and Centers for Disease Control and Prevention (M.M.-E., J.M.J., H.C.B.), Atlanta, GA.ORCID 0000-0001-6587-2297
Maria Morel-EspinosaFrom the Department of Internal Medicine (O.K.S., L.H.), University of Zambia School of Medicine, Lusaka; Global Neurology Program (O.K.S.), Division of Neuroimmunology, Center for Virology and Vaccine Research, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; Ministry of Health (M.K., E.C.-K.); ASPPH/CDC Allan Rosenfield Global Health Fellowship Program (R.K.), Lusaka; Department of Public Health and Research (A.N.M.) and Zambia Field Epidemiology Training Program (P.K.), Ministry of Health; World Health Organization (M.L.M.); Virology Laboratory (M.L.M.) and Department of Physiotherapy (M.N.M.), Children's Hospital, University Teaching Hospital, Lusaka, Zambia; Institute of Human Virology (L.H.), Division of Infectious Diseases, Department of Medicine, University of Maryland School of Medicine, Baltimore; Zambia Agriculture Research Institute (P.C.C.), Plant Protection and Quarantine Division, Lusaka; and Centers for Disease Control and Prevention (M.M.-E., J.M.J., H.C.B.), Atlanta, GA.ORCID 0000-0002-8779-1591
Jeffery M JarrettFrom the Department of Internal Medicine (O.K.S., L.H.), University of Zambia School of Medicine, Lusaka; Global Neurology Program (O.K.S.), Division of Neuroimmunology, Center for Virology and Vaccine Research, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; Ministry of Health (M.K., E.C.-K.); ASPPH/CDC Allan Rosenfield Global Health Fellowship Program (R.K.), Lusaka; Department of Public Health and Research (A.N.M.) and Zambia Field Epidemiology Training Program (P.K.), Ministry of Health; World Health Organization (M.L.M.); Virology Laboratory (M.L.M.) and Department of Physiotherapy (M.N.M.), Children's Hospital, University Teaching Hospital, Lusaka, Zambia; Institute of Human Virology (L.H.), Division of Infectious Diseases, Department of Medicine, University of Maryland School of Medicine, Baltimore; Zambia Agriculture Research Institute (P.C.C.), Plant Protection and Quarantine Division, Lusaka; and Centers for Disease Control and Prevention (M.M.-E., J.M.J., H.C.B.), Atlanta, GA.ORCID 0000-0001-5755-3552
Henry C BaggettFrom the Department of Internal Medicine (O.K.S., L.H.), University of Zambia School of Medicine, Lusaka; Global Neurology Program (O.K.S.), Division of Neuroimmunology, Center for Virology and Vaccine Research, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; Ministry of Health (M.K., E.C.-K.); ASPPH/CDC Allan Rosenfield Global Health Fellowship Program (R.K.), Lusaka; Department of Public Health and Research (A.N.M.) and Zambia Field Epidemiology Training Program (P.K.), Ministry of Health; World Health Organization (M.L.M.); Virology Laboratory (M.L.M.) and Department of Physiotherapy (M.N.M.), Children's Hospital, University Teaching Hospital, Lusaka, Zambia; Institute of Human Virology (L.H.), Division of Infectious Diseases, Department of Medicine, University of Maryland School of Medicine, Baltimore; Zambia Agriculture Research Institute (P.C.C.), Plant Protection and Quarantine Division, Lusaka; and Centers for Disease Control and Prevention (M.M.-E., J.M.J., H.C.B.), Atlanta, GA.ORCID 0000-0002-7620-5569
Elizabeth Chizema-KaweshaFrom the Department of Internal Medicine (O.K.S., L.H.), University of Zambia School of Medicine, Lusaka; Global Neurology Program (O.K.S.), Division of Neuroimmunology, Center for Virology and Vaccine Research, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; Ministry of Health (M.K., E.C.-K.); ASPPH/CDC Allan Rosenfield Global Health Fellowship Program (R.K.), Lusaka; Department of Public Health and Research (A.N.M.) and Zambia Field Epidemiology Training Program (P.K.), Ministry of Health; World Health Organization (M.L.M.); Virology Laboratory (M.L.M.) and Department of Physiotherapy (M.N.M.), Children's Hospital, University Teaching Hospital, Lusaka, Zambia; Institute of Human Virology (L.H.), Division of Infectious Diseases, Department of Medicine, University of Maryland School of Medicine, Baltimore; Zambia Agriculture Research Institute (P.C.C.), Plant Protection and Quarantine Division, Lusaka; and Centers for Disease Control and Prevention (M.M.-E., J.M.J., H.C.B.), Atlanta, GA.ORCID 0000-0003-3817-2388
University of Maryland, Baltimore · US
Funding
World Health Organization 001
6 · The paper itself
Abstract
objectiveTo identify the etiology of an outbreak of spastic paraparesis among women and children in the Western Province of Zambia suspected to be konzo.
methodsWe conducted an outbreak investigation of individuals from Mongu District, Western Province, Zambia, who previously developed lower extremity weakness. Cases were classified with the World Health Organization definition of konzo. Active case finding was conducted through door-to-door evaluation in affected villages and sensitization at local health clinics. Demographic, medical, and dietary history was used to identify common exposures in all cases. Urine and blood specimens were taken to evaluate for konzo and alternative etiologies.
resultsWe identified 32 cases of konzo exclusively affecting children 6 to 14 years of age and predominantly females >14 years of age. Fourteen of 15 (93%) cases ≥15 years of age were female, 11 (73%) of whom were breastfeeding at the time of symptom onset. Cassava was the most commonly consumed food (median [range] 14 [4-21] times per week), while protein-rich foods were consumed <1 time per week for all cases. Of the 30 patients providing urine specimens, median thiocyanate level was 281 (interquartile range 149-522) μmol/L, and 73% of urine samples had thiocyanate levels >136 μmol/L, the 95th percentile of the US population in 2013 to 2014.
conclusionThis investigation revealed the first documented cases of konzo in Zambia, occurring in poor communities with diets high in cassava and low in protein, consistent with previous descriptions from neighboring countries.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Konzo outbreak in the Western Province of Zambia. · full record | OpenQuestion